|
1
|
Merkel OM, Rubinstein I and Kissel T:
siRNA delivery to the lung: What's new? Adv Drug Deliv Rev.
75:112–128. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fujita Y, Takeshita F, Kuwano K and Ochiya
T: RNAi Therapeutic platforms for lung diseases. Pharmaceuticals
(Basel). 6:223–250. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fehring V, Schaeper U, Ahrens K, Santel A,
Keil O, Eisermann M, Giese K and Kaufmann J: Delivery of
therapeutic siRNA to the lung endothelium via novel Lipoplex
formulation DACC. Mol Ther. 22:811–820. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Garbuzenko OB, Saad M, Betigeri S, Zhang
M, Vetcher AA, Soldatenkov VA, Reimer DC, Pozharov VP and Minko T:
Intratracheal versus intravenous liposomal delivery of siRNA,
antisense oligonucleotides and anticancer drug. Pharm Res.
26:382–394. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Merkel OM and Kissel T: Nonviral pulmonary
delivery of siRNA. Acc Chem Res. 45:961–970. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McCaskill J, Singhania R, Burgess M,
Allavena R, Wu S, Blumenthal A and McMillan NA: Efficient
biodistribution and gene silencing in the lung epithelium via
intravenous liposomal delivery of siRNA. Mol Ther Nucleic Acids.
2:e962013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kuruba R, Wilson A, Gao X and Li S:
Targeted delivery of nucleic-acid-based therapeutics to the
pulmonary circulation. AAPS J. 11:23–30. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hattori Y, Nakamura M, Takeuchi N, Tamaki
K, Shimizu S, Yoshiike Y, Taguchi M, Ohno H, Ozaki KI and Onishi H:
Effect of cationic lipid in cationic liposomes on siRNA delivery
into the lung by intravenous injection of cationic lipoplex. J Drug
Target. 27:217–227. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hattori Y, Tamaki K, Ozaki K, Kawano K and
Onishi H: Optimized combination of cationic lipids and neutral
helper lipids in cationic liposomes for siRNA delivery into the
lung by intravenous injection of siRNA lipoplexes. J Drug Deliv Sci
Technol. 52:1042–1050. 2019. View Article : Google Scholar
|
|
10
|
Hattori Y, Shimizu S, Ozaki KI and Onishi
H: Effect of cationic lipid type in folate-PEG-modified cationic
liposomes on folate receptor-mediated siRNA transfection in tumor
cells. Pharmaceutics. 11:112019. View Article : Google Scholar
|
|
11
|
Hattori Y, Nakamura A, Arai S, Kawano K,
Maitani Y and Yonemochi E: siRNA delivery to lung-metastasized
tumor by systemic injection with cationic liposomes. J Liposome
Res. 25:279–286. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hattori Y, Arai S, Kikuchi T, Ozaki KI,
Kawano K and Yonemochi E: Therapeutic effect for liver-metastasized
tumor by sequential intravenous injection of anionic polymer and
cationic lipoplex of siRNA. J Drug Target. 24:309–317. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aleku M, Schulz P, Keil O, Santel A,
Schaeper U, Dieckhoff B, Janke O, Endruschat J, Durieux B, Röder N,
et al: Atu027, a liposomal small interfering RNA formulation
targeting protein kinase N3, inhibits cancer progression. Cancer
Res. 68:9788–9798. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hattori Y, Tamaki K, Sakasai S, Ozaki KI
and Onishi H: Effects of PEG anchors in PEGylated siRNA lipoplexes
on in vitro gene silencing effects and siRNA biodistribution in
mice. Mol Med Rep. 22:4183–4196. 2020.PubMed/NCBI
|
|
15
|
Hattori Y, Nakamura T, Ohno H, Fujii N and
Maitani Y: siRNA delivery into tumor cells by lipid-based
nanoparticles composed of hydroxyethylated cholesteryl triamine.
Int J Pharm. 443:221–229. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sato A, Ohtsuki M, Hata M, Kobayashi E and
Murakami T: Antitumor activity of IFN-lambda in murine tumor
models. J Immunol. 176:7686–7694. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oku T, Ando Y, Ogura M and Tsuji T:
Development of splice variant-specific monoclonal antibodies
against human alpha3 integrin. Monoclon Antib Immunodiagn
Immunother. 35:12–17. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oku T, Shimada K, Kenmotsu H, Ando Y,
Kurisaka C, Sano R, Tsuiji M, Hasegawa S, Fukui T and Tsuji T:
Stimulation of peritoneal mesothelial cells to secrete matrix
metalloproteinase-9 (MMP-9) by TNF-alpha: A role in the invasion of
gastric carcinoma cells. Int J Mol Sci. 19:192018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hattori Y, Nakamura A, Hanaya S, Miyanabe
Y, Yoshiike Y, Kikuchi T, Ozaki K and Onishi H: Effect of
chondroitin sulfate on siRNA biodistribution and gene silencing
effect in mice after injection of siRNA lipoplexes. J Drug Deliv
Sci Technol. 41:401–409. 2017. View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu Z, He B, Ma L, Sun Y, Niu Y and Zeng B:
Recent advances in ergosterol biosynthesis and regulation
mechanisms in Saccharomyces cerevisiae. Indian J Microbio.
57:270–277. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Benveniste P: Biosynthesis and
accumulation of sterols. Annu Rev Plant Biol. 55:429–457. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Eliyahu H, Servel N, Domb AJ and Barenholz
Y: Lipoplex-induced hemagglutination: Potential involvement in
intravenous gene delivery. Gene Ther. 9:850–858. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Simberg D, Weisman S, Talmon Y, Faerman A,
Shoshani T and Barenholz Y: The role of organ vascularization and
lipoplex-serum initial contact in intravenous murine lipofection. J
Biol Chem. 278:39858–39865. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Loughna S and Sato TN: Angiopoietin and
Tie signaling pathways in vascular development. Matrix Biol.
20:319–325. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
van der Heijden M, van Nieuw Amerongen GP,
Chedamni S, van Hinsbergh VW and Johan Groeneveld AB: The
angiopoietin-Tie2 system as a therapeutic target in sepsis and
acute lung injury. Expert Opin Ther Targets. 13:39–53. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Loisel S, Le Gall C, Doucet L, Ferec C and
Floch V: Contribution of plasmid DNA to hepatotoxicity after
systemic administration of lipoplexes. Hum Gene Ther. 12:685–696.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen S, Yong T, Zhang Y, Su J, Jiao C and
Xie Y: Anti-tumor and Anti-angiogenic Ergosterols from Ganoderma
lucidum. Front Chem. 5:852017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Takaku T, Kimura Y and Okuda H: Isolation
of an antitumor compound from Agaricus blazei Murill and its
mechanism of action. J Nutr. 131:1409–1413. 2001. View Article : Google Scholar : PubMed/NCBI
|
